{"id":109592,"date":"2026-08-08T06:29:52","date_gmt":"2026-08-08T06:29:52","guid":{"rendered":"https:\/\/indianweekend.in\/index.php\/2026\/08\/08\/chandan-healthcare-sharpens-focus-on-high-margin-diagnostics-business-through-strategic-divestment\/"},"modified":"2026-08-08T06:29:52","modified_gmt":"2026-08-08T06:29:52","slug":"chandan-healthcare-sharpens-focus-on-high-margin-diagnostics-business-through-strategic-divestment","status":"publish","type":"post","link":"https:\/\/indianweekend.in\/index.php\/2026\/08\/08\/chandan-healthcare-sharpens-focus-on-high-margin-diagnostics-business-through-strategic-divestment\/","title":{"rendered":"Chandan Healthcare Sharpens Focus on High-Margin Diagnostics Business Through Strategic Divestment"},"content":{"rendered":"<div>\n<p class=\"wp-block-paragraph\"><strong>Lucknow (Uttar Pradesh) [India], August 8:<\/strong> <strong>Chandan Healthcare\u00a0Limited (NSE \u2013 CHANDAN), <\/strong>one of the leading diagnostic and healthcare services providers, has announced the strategic divestment of its entire shareholding in Chandan Pharmacy Limited (\u201cCPL\u201d), reinforcing its focus on scaling its core, higher-margin diagnostics business.<\/p>\n<p class=\"wp-block-paragraph\">The divestment aligns with Chandan Healthcare\u2019s strategy to sharpen its focus on the higher-margin diagnostics business. The transaction will simplify the business structure and enable greater management and capital allocation towards expanding the Company\u2019s core diagnostics operations.<\/p>\n<p class=\"wp-block-paragraph\"><strong>Key Strategic Benefits<\/strong><\/p>\n<ul class=\"wp-block-list\">\n<li><strong>Improved Margin Profile:<\/strong>\u00a0Deconsolidation of the lower-margin pharmacy business is expected to improve the overall business mix and enable the stronger profitability of diagnostics to reflect more clearly in the Company\u2019s consolidated financial performance.<\/li>\n<li><strong>Sharper Focus on Core Diagnostics:<\/strong>\u00a0Greater management bandwidth and resources can be directed towards expanding the diagnostics network, increasing capacity utilisation and scaling the Company\u2019s core operations.<\/li>\n<li><strong>Capital Redeployment Towards Higher-Return Assets:<\/strong>\u00a0Proceeds from the divestment are proposed to be deployed towards the development of new diagnostic centres and capacity expansion. This will enable the Company to reallocate capital from a lower-margin business towards higher-EBITDA opportunities.<\/li>\n<li><strong>Simplified Business Structure:<\/strong>\u00a0A more focused diagnostics-led structure is expected to provide greater visibility into the scale, growth and profitability of the core business while enabling more relevant benchmarking with diagnostics-focused peers.<\/li>\n<\/ul>\n<p class=\"wp-block-paragraph\"><strong>Transaction Details<\/strong><\/p>\n<p class=\"wp-block-paragraph\">The Board has approved the divestment of Chandan Healthcare\u2019s entire\u00a0<strong>53.56% stake in Chandan Pharmacy Limited to Chandan Hospital Limited<\/strong>\u00a0for a consideration of approximately\u00a0<strong>\u20b9<\/strong><strong>16.77 crore<\/strong>. The consideration is based on CPL\u2019s independently determined total valuation of approximately\u00a0<strong>\u20b9<\/strong><strong>31.31 crore<\/strong>, following which CPL will cease to be a subsidiary of the Company.<\/p>\n<h3 class=\"wp-block-heading\"><strong>Building a Focused Diagnostics Platform<\/strong><\/h3>\n<p class=\"wp-block-paragraph\">Going forward, Chandan Healthcare intends to deploy greater financial and managerial resources towards expanding its diagnostics footprint, adding new centres, strengthening capacity and driving higher utilisation across its network.<\/p>\n<p class=\"wp-block-paragraph\">The strategic realignment is expected to result in a simpler and more focused business structure, with a stronger margin profile and future growth increasingly driven by the scale-up of the Company\u2019s core diagnostics operations.<\/p>\n<h3 class=\"wp-block-heading\"><strong>About Chandan Healthcare Limited<\/strong><\/h3>\n<p class=\"wp-block-paragraph\">Chandan Healthcare Limited, established in 2003, is one of India\u2019s leading providers of diagnostic and pharmacy services and a key entity of the Chandan Group. The Company delivers a comprehensive range of pathology and radiology services through its expanding network across India.<\/p>\n<p class=\"wp-block-paragraph\">As on June 30, 2026, the Company operates 327 diagnostic centres including 264 operational franchise centres, strengthening its presence across urban, semi-urban and emerging markets. Its diagnostic portfolio comprises more than 3,000 pathology tests and 500+ radiology tests, including blood tests, X-ray, ECG, Ultrasound, CT scan, MRI and several other specialized diagnostic investigations. The Company\u2019s network includes NABL and NABH accredited pathology laboratories and radiology centres, reflecting its commitment to delivering reliable, high-quality diagnostic services.<\/p>\n<p class=\"wp-block-paragraph\">Chandan Healthcare operates through a diversified business model comprising B2C (Retail Customers), B2B (Institutional &amp; Corporate Clients) and B2G (Government PPP Contracts), providing a balanced and scalable revenue profile while catering to a wide spectrum of healthcare needs.<\/p>\n<p class=\"wp-block-paragraph\">The Company was listed on the NSE Emerge platform on February 17, 2025.\u00a0<\/p>\n<p class=\"wp-block-paragraph\">During FY26, the Company reported Total Income of\u00a0\u20b9280.67 Cr, EBITDA of\u00a0\u20b956.84 Cr and Profit After Tax (PAT) of\u00a0\u20b927.06 Cr, reflecting its continued operational growth and financial strength.<\/p>\n<p class=\"wp-block-paragraph\"><em>If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.<\/em><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Lucknow (Uttar Pradesh) [India], August 8: Chandan Healthcare\u00a0Limited (NSE \u2013 CHANDAN), one of the leading diagnostic and healthcare services providers, has announced the strategic divestment of its entire shareholding in Chandan Pharmacy Limited (\u201cCPL\u201d), reinforcing its focus on scaling its core, higher-margin diagnostics business. The divestment aligns with Chandan Healthcare\u2019s strategy to sharpen its focus [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":109593,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[116],"tags":[19],"class_list":["post-109592","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-business"],"_links":{"self":[{"href":"https:\/\/indianweekend.in\/index.php\/wp-json\/wp\/v2\/posts\/109592","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/indianweekend.in\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/indianweekend.in\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/indianweekend.in\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/indianweekend.in\/index.php\/wp-json\/wp\/v2\/comments?post=109592"}],"version-history":[{"count":0,"href":"https:\/\/indianweekend.in\/index.php\/wp-json\/wp\/v2\/posts\/109592\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/indianweekend.in\/index.php\/wp-json\/wp\/v2\/media\/109593"}],"wp:attachment":[{"href":"https:\/\/indianweekend.in\/index.php\/wp-json\/wp\/v2\/media?parent=109592"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/indianweekend.in\/index.php\/wp-json\/wp\/v2\/categories?post=109592"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/indianweekend.in\/index.php\/wp-json\/wp\/v2\/tags?post=109592"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}